| Aug 22, 2011
| 11:50 AM
The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost.
The U.S. Food and Drug Administration on Friday gave its nod to Adcetris, the first...
| May 23, 2011
| 3:53 PM
Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co.
Incivek, a pill...
| Nov 7, 2009
Teenagers and young adults suffering from severe, scarring acne may ultimately lose the most effective treatment for the condition.
FOR THE RECORD:
Accutane's side effects: An article in Saturday's Section A about the possibility of...
| Oct 19, 2005
Should a deadly bird flu spread quickly around the world, Americans could find themselves at the back of the line for any new vaccine developed to combat it.
There are few U.S. vaccine makers. And even those, such as Deerfield-based Baxter...